<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230501058035N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-23</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Investigation improvement following an exercise rehabilitation period in cardiac patients after angioplasty.</public_title>
      <acronym></acronym>
      <scientific_title>Investigation and comparison of clinical status improvement following an exercise rehabilitation period in cardiac patients after right coronary artery (RCA) or left anterior descending coronary artery (LAD) angioplasty.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70075</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>2-3</phase>
      <hc_freetext>cardiac patients after coronary artery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The said test consists of seven stages of three minutes. The first stage starts with a treadmill slope of 10%, and in each stage, 2% is added to the slope. Also, the treadmill's speed in the first stage is 2.74 km/h, which increases increasingly in the later stages. In sports training sessions, each session will begin with a standard warm-up phase, which includes 5 minutes of light-intensity activity and static and dynamic stretching exercises. The main part of the training session consists of two separate parts. In the aerobic exercise section, each person exercises with moderate intensity (Met 3-6 or pressure perception scale 12-13 on the 15-value Borg scale) according to his maximum aerobic capacity obtained in the test. In the second part of the training session, after the aerobic exercise, light resistance exercises using body weight and dumbbells are performed for the patients by the physiotherapist. At the end of the training session, cooling is adopted to prevent parasympathetic reflexes. It is necessary to explain that in the aerobic training section, each person will train alternately in three sessions a week with a treadmill, foot ergometer, and manual ergometer. The exercises will be carried out three days a week and finally for eight weeks. Intervention 2: Intervention group: The said test consists of seven stages of three minutes. The first stage starts with a treadmill slope of 10%, and in each stage, 2% is added to the slope. Also, the treadmill's speed in the first stage is 2.74 km/h, which increases increasingly in the later stages. In sports training sessions, each session will begin with a standard warm-up phase, which includes 5 minutes of light-intensity activity and static and dynamic stretching exercises. The main part of the training session consists of two separate parts. In the aerobic exercise section, each person exercises with moderate intensity (Met 3-6 or pressure perception scale 12-13 on the 15-value Borg scale) according to his maximum aerobic capacity obtained in the test. In the second part of the training session, after the aerobic exercise, light resistance exercises using body weight and dumbbells are performed for the patients by the physiotherapist. At the end of the training session, cooling is adopted to prevent parasympathetic reflexes. It is necessary to explain that in the aerobic training section, each person will train alternately in three sessions a week with a treadmill, foot ergometer, and manual ergometer. The exercises will be carried out three days a week and finally for eight weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only a part of the data, such as the information related to the main outcome or the like, can be shared.

When:
The access period starts 6 months after the results are published

To whom:
Our data will only be available to researchers working in academic and scientific institutions.

Conditions:
Our data will be available to all scientific researchers who request via official email.

Where to obtain:
z.shaghaghi@umsha.ac.ur via email

How to obtain:
Researchers will receive the data by sending a data access request six months after the article's publication by sending an email to z.shaghaghi@umsha.ac.ur.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amir Hossein Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Farshchian Cardiovascular Subspecialty Medical Center, Shahid Fahmideh Ave, Hamadan City, Iran</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517839131</zip>
        <telephone>+98 81 3838 1740</telephone>
        <email>amirhoseyn.yazdi@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Lobat Majidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Farshchian Cardiovascular Subspecialty Medical Center, Shahid Fahmideh Ave, Hamadan City, Iran</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517839131</zip>
        <telephone>+98 918 315 8983</telephone>
        <email>l.majidi@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who have undergone coronary artery angioplasty and refer to the cardiac rehabilitation department</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient has not undergone valve repair surgeries.
Absence of severe heart failure.
Absence of movement problems and debilitating environmental joint diseases, and severe skeletal disorders
Absence of debilitating cognitive disorders
No history of heart or thorax surgery
Not involving more than one coronary vessel in angioplasty
No history of congenital heart problems
The patient does not have pericardial perfusion experience.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z95.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Presence of coronary angioplasty implant and graft</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The said test consists of seven stages of three minutes. The first stage starts with a treadmill slope of 10%, and in each stage, 2% is added to the slope. Also, the treadmill's speed in the first stage is 2.74 km/h, which increases increasingly in the later stages. In sports training sessions, each session will begin with a standard warm-up phase, which includes 5 minutes of light-intensity activity and static and dynamic stretching exercises. The main part of the training session consists of two separate parts. In the aerobic exercise section, each person exercises with moderate intensity (Met 3-6 or pressure perception scale 12-13 on the 15-value Borg scale) according to his maximum aerobic capacity obtained in the test. In the second part of the training session, after the aerobic exercise, light resistance exercises using body weight and dumbbells are performed for the patients by the physiotherapist. At the end of the training session, cooling is adopted to prevent parasympathetic reflexes. It is necessary to explain that in the aerobic training section, each person will train alternately in three sessions a week with a treadmill, foot ergometer, and manual ergometer. The exercises will be carried out three days a week and finally for eight weeks.</i_keyword>
      <i_keyword>Intervention group: The said test consists of seven stages of three minutes. The first stage starts with a treadmill slope of 10%, and in each stage, 2% is added to the slope. Also, the treadmill's speed in the first stage is 2.74 km/h, which increases increasingly in the later stages. In sports training sessions, each session will begin with a standard warm-up phase, which includes 5 minutes of light-intensity activity and static and dynamic stretching exercises. The main part of the training session consists of two separate parts. In the aerobic exercise section, each person exercises with moderate intensity (Met 3-6 or pressure perception scale 12-13 on the 15-value Borg scale) according to his maximum aerobic capacity obtained in the test. In the second part of the training session, after the aerobic exercise, light resistance exercises using body weight and dumbbells are performed for the patients by the physiotherapist. At the end of the training session, cooling is adopted to prevent parasympathetic reflexes. It is necessary to explain that in the aerobic training section, each person will train alternately in three sessions a week with a treadmill, foot ergometer, and manual ergometer. The exercises will be carried out three days a week and finally for eight weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The percentage of heart patients who underwent coronary artery angioplasty. Timepoint: The systolic and diastolic function of the heart's left ventricle will be measured in two stages (before the beginning of the training period and after its completion). Method of measurement: Using an echocardiography device using the Simpson method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-11</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Shahid Fahmideh st, Hamadan, Hamadan, Iran Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
